Cargando…
Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
CRIPTO-(CR)1 is a protein associated with tumorigenesis and metastasis. Here we demonstrate that CR-1 expression in normal and creta placentas is associated with various degrees of uterine invasion. Cytokeratin (CK) and CR-1 protein expression was visualized by immunohistochemical staining of formal...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140153/ https://www.ncbi.nlm.nih.gov/pubmed/25165718 http://dx.doi.org/10.1155/2014/892856 |
_version_ | 1782331480517640192 |
---|---|
author | Bandeira, Carla Letícia Urban Borbely, Alexandre Pulcineli Vieira Francisco, Rossana Schultz, Regina Zugaib, Marcelo Bevilacqua, Estela |
author_facet | Bandeira, Carla Letícia Urban Borbely, Alexandre Pulcineli Vieira Francisco, Rossana Schultz, Regina Zugaib, Marcelo Bevilacqua, Estela |
author_sort | Bandeira, Carla Letícia |
collection | PubMed |
description | CRIPTO-(CR)1 is a protein associated with tumorigenesis and metastasis. Here we demonstrate that CR-1 expression in normal and creta placentas is associated with various degrees of uterine invasion. Cytokeratin (CK) and CR-1 protein expression was visualized by immunohistochemical staining of formalin-fixed, paraffin-embedded placental specimens (control placentas, n = 9; accreta, n = 6; increta, n = 10; percreta, n = 15). The pattern of extravillous trophoblast (EVT) cell morphology was distinctive in creta placentas: densely-compacted cell columns and large star-shaped cells with a typically migratory phenotype, not common among third trimester control placentas. Quantification revealed higher CR-1 immunoreactivities in accreta (P = 0.001), increta (P = 0.0002), and percreta placentas (P = 0.001) than in controls. In contrast to controls, there was a significant positive relationship between CR-1 and CK reactivity in all creta placentas (accreta, P = 0.02; increta, P = 0.0001, and percreta, P = 0.025). This study demonstrated CR-1 expression in the placental bed, its increased expression in creta placentas, and EVT cells as the main CR-1-producing cell type. Morphological examination revealed an immature and invasive trophoblast profile in creta placentas, suggesting impairment of the trophoblast differentiation pathway. These findings provide important new insights into the pathophysiology of abnormal creta placentation and its gestational consequences. |
format | Online Article Text |
id | pubmed-4140153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-41401532014-08-27 Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta Bandeira, Carla Letícia Urban Borbely, Alexandre Pulcineli Vieira Francisco, Rossana Schultz, Regina Zugaib, Marcelo Bevilacqua, Estela Biomed Res Int Research Article CRIPTO-(CR)1 is a protein associated with tumorigenesis and metastasis. Here we demonstrate that CR-1 expression in normal and creta placentas is associated with various degrees of uterine invasion. Cytokeratin (CK) and CR-1 protein expression was visualized by immunohistochemical staining of formalin-fixed, paraffin-embedded placental specimens (control placentas, n = 9; accreta, n = 6; increta, n = 10; percreta, n = 15). The pattern of extravillous trophoblast (EVT) cell morphology was distinctive in creta placentas: densely-compacted cell columns and large star-shaped cells with a typically migratory phenotype, not common among third trimester control placentas. Quantification revealed higher CR-1 immunoreactivities in accreta (P = 0.001), increta (P = 0.0002), and percreta placentas (P = 0.001) than in controls. In contrast to controls, there was a significant positive relationship between CR-1 and CK reactivity in all creta placentas (accreta, P = 0.02; increta, P = 0.0001, and percreta, P = 0.025). This study demonstrated CR-1 expression in the placental bed, its increased expression in creta placentas, and EVT cells as the main CR-1-producing cell type. Morphological examination revealed an immature and invasive trophoblast profile in creta placentas, suggesting impairment of the trophoblast differentiation pathway. These findings provide important new insights into the pathophysiology of abnormal creta placentation and its gestational consequences. Hindawi Publishing Corporation 2014 2014-08-06 /pmc/articles/PMC4140153/ /pubmed/25165718 http://dx.doi.org/10.1155/2014/892856 Text en Copyright © 2014 Carla Letícia Bandeira et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bandeira, Carla Letícia Urban Borbely, Alexandre Pulcineli Vieira Francisco, Rossana Schultz, Regina Zugaib, Marcelo Bevilacqua, Estela Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta |
title | Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta |
title_full | Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta |
title_fullStr | Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta |
title_full_unstemmed | Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta |
title_short | Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta |
title_sort | tumorigenic factor cripto-1 is immunolocalized in extravillous cytotrophoblast in placenta creta |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140153/ https://www.ncbi.nlm.nih.gov/pubmed/25165718 http://dx.doi.org/10.1155/2014/892856 |
work_keys_str_mv | AT bandeiracarlaleticia tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta AT urbanborbelyalexandre tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta AT pulcinelivieirafranciscorossana tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta AT schultzregina tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta AT zugaibmarcelo tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta AT bevilacquaestela tumorigenicfactorcripto1isimmunolocalizedinextravillouscytotrophoblastinplacentacreta |